Trisomy of chromosome 21 in leukemogenesis

被引:33
作者
Izraeli, Shai [1 ]
Rainis, Liat
Hertzberg, Libi
Smooha, Gil
Birger, Yeliudit
机构
[1] Res Sect Childhood Malignancies, Dept Pediat Hemato Oncol, IL-52621 Tel Hashomer, Israel
[2] Sheba Med Hosp, Sheba Canc Res Ctr, IL-52621 Tel Hashomer, Israel
基金
以色列科学基金会;
关键词
down syndrome; chromosome; 21; childhood leukemia; megakaryoblastic leukemia; GATA1; acute lymphoblastic leukemia;
D O I
10.1016/j.bcmd.2007.04.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Extra copies of chromosome 21 are often found in sporadic leukemias. Constitutional trisomy 21 of Down syndrome (DS) is associated with markedly increased risk for childhood leukemia. Thus the oncogenic role oftrisomy 21 in the more common sporadic childhood leukemias may be revealed through the investigations of the relatively rare leukemias of DS. Recent studies of the megakaryoblastic leukemias of Down syndrome have uncovered a developmental leukemogenic mechanism characterized by a unique pre-natal collaboration between overexpressed genes from chromosome 21 and an acquired mutation in the transcription factor GATA 1. The base of the markedly enhanced risk for acute lymphoblastic leukemia conferred by trisomy 21 is still unclear. Studies of the leukemias of DS are likely to contribute to the general understanding of the oncogenic, mechanisms of chromosomal aneuploidies, the most common abnormalities in cancer. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:156 / 159
页数:4
相关论文
共 27 条
[1]   Lymphoblast biology and outcome among children with Down syndrome and ALL treated on CCG-1952 [J].
Bassal, M ;
La, MK ;
Whitlock, JA ;
Sather, HN ;
Heerema, NA ;
Gaynon, PS ;
Stork, LC .
PEDIATRIC BLOOD & CANCER, 2005, 44 (01) :21-28
[2]  
CRIPINO JD, 2005, SEMIN CELL DEV BIOL, V16, P137
[3]   Gene expression analysis reveals a strong signature of an interferon-induced pathway in childhood lymphoblastic leukemia as well as in breast and ovarian cancer [J].
Einav, U ;
Tabach, Y ;
Getz, G ;
Yitzhaky, A ;
Ozbek, U ;
Amariglio, N ;
Izraeli, S ;
Rechavi, G ;
Domany, E .
ONCOGENE, 2005, 24 (42) :6367-6375
[4]   RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation [J].
Elagib, KE ;
Racke, FK ;
Mogass, M ;
Khetawat, R ;
Delehanty, LL ;
Goldfarb, AN .
BLOOD, 2003, 101 (11) :4333-4341
[5]   Cytogenetic abnormalities in childhood acute myeloid leukaemia:: a Nordic series comprising all children enrolled in the NOPHO-93-AML trial between 1993 and 2001 [J].
Forestier, E ;
Heim, S ;
Blennow, E ;
Borgström, G ;
Holmgren, G ;
Heinonen, K ;
Johannsson, J ;
Kerndrup, G ;
Andersen, MK ;
Lundin, C ;
Nordgren, A ;
Rosenquist, R ;
Swolin, B ;
Johansson, B .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (04) :566-577
[6]   MicroRNA fingerprints during human megakaryocytopoiesis [J].
Garzon, R ;
Pichiorri, F ;
Palumbo, T ;
Iuliano, R ;
Cimmino, A ;
Aqeilan, R ;
Volinia, S ;
Bhatt, D ;
Alder, H ;
Marcucci, G ;
Calin, GA ;
Liu, CG ;
Bloomfield, CD ;
Andreeff, M ;
Croce, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (13) :5078-5083
[7]  
Greaves Mel, 2003, Rev Clin Exp Hematol, V7, P233
[8]   Aetiology of acute leukaemia [J].
Greaves, MF .
LANCET, 1997, 349 (9048) :344-349
[9]   The detection and significance of chromosomal abnormalities in childhood acute lymphoblastic leukaemia [J].
Harrison, CJ .
BLOOD REVIEWS, 2001, 15 (01) :49-59
[10]   A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases [J].
Hasle, H ;
Niemeyer, CM ;
Chessells, JM ;
Baumann, I ;
Bennett, JM ;
Kerndrup, G ;
Head, DR .
LEUKEMIA, 2003, 17 (02) :277-282